Hims vs Zealthy: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher

53 providers verified independently·Independent research·How we rank →

Visit Embody - our featured pick→or find your match

Hims beats Zealthy overall, scoring 7.9/10 vs 7.2/10. Hims is more affordable at $149/mo vs $286/mo. Choose Hims for men who want a well-known publicly-traded brand and fda-appr. Choose Zealthy for insured users who want dedicated coordinators handling prior.

A side-by-side look at Hims and Zealthy to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Higher Rated

Hims

#7 of 53

7.9/10

The household name in men's telehealth, publicly traded as Hims & Hers Health (NYSE: HIMS). In 2026 Hims added FDA-approved brand-name Wegovy (injection and pill) and Ozempic through a direct Novo Nordisk partnership, and has since exited compounded semaglutide for new patients, so the retail lineup is FDA-approved brand only. Its parent still reports offering access to compounded GLP-1 medications on a limited scale (Q2 2026 results, filed with the SEC August 10, 2026). Brand recognition and product breadth are real strengths. The trade-off: Hims' verified Trustpilot rating is 3.0 stars across 8,286 reviews (May 2026), significantly below smaller competitors like Henry Meds (4.5) or Eden Health (4.5). The 1-star pool is 28%, the highest 1-star rate in our table, clustered around subscription/billing complaints.

Visit Hims

Zealthy

#38 of 53

7.2/10

Flexible GLP-1 provider allowing patients to switch between compounded and brand-name medications as needed.

Visit Zealthy

Feature	Hims	Zealthy
Why each one	The only publicly-traded men's telehealth (NYSE: HIMS) with FDA-approved Wegovy via direct Novo Nordisk partnership. Brand-name access plus SEC accountability, but balanced against a 3.0 Trustpilot rating that lags peers.	Dedicated insurance coordinators handle prior authorizations for brand-name GLP-1s, plus multi-month supply options up to 12 months.
Our Score	7.9/10	7.2/10
Starting Price	$149/mo	$286/mo
Medication Type	Both	Both
Insurance Accepted	No	No
Best For	Men who want a well-known publicly-traded brand and FDA-approved Wegovy through the 2026 Novo Nordisk partnership, but should know going in that Hims' customer-experience signal is weaker than smaller competitors	Insured users who want dedicated coordinators handling prior authorizations for brand-name GLP-1s (potentially $25/mo)
Watch out for	Pending federal enforcement action. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings, and Hims has not been found liable.	The $135 membership stacks on medication cost, so cash-pay semaglutide totals ~$286/mo, above average. The math works when you use the insurance coordination; cash payers should compare flat-rate platforms first.
Ranking	#7	#38
Get started	Visit Hims	Visit Zealthy

Pros & Cons Compared

Hims

Pros

+Publicly traded company (NYSE: HIMS), SEC-filed financials, regulatory accountability that private competitors don't have.
+2026 Novo Nordisk partnership, FDA-approved Wegovy injection, Wegovy pill, and Ozempic now available directly through Hims. Real brand-name access from a single platform.
+$199/mo all-inclusive for compounded semaglutide, including consultations and shipping.
+Polished app and web experience, among the best user interfaces in men's telehealth.
+8,286 verified Trustpilot reviews is the second-largest review volume in our table (after Henry's 12,461), significant real-world adoption.

Cons

−Pending federal enforcement action. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings, and Hims has not been found liable.
−Trustpilot rating is 3.0 stars / 8,286 reviews (May 2026), significantly below Henry Meds (4.5), Eden Health (4.5), Yucca Health (4.6), MEDVi (4.4). The lowest customer-experience signal of any major brand we track.
−28% of Trustpilot reviews are 1-star, the highest 1-star rate in our table. Top complaint themes: subscription handling, unexpected charges, customer service responsiveness.
−Hims reviews span ALL their products (ED, hair loss, mental health, weight loss), not just GLP-1. But the rating still applies because most users don't separate experiences by product.
−'Hims Oral Kit' is NOT a GLP-1, it's a non-GLP-1 metabolic combination (metformin + bupropion + topiramate + B12 + naltrexone). Easy to confuse with their compounded semaglutide. Read the product page carefully before signing up.
−Cash-pay only, Hims does not bill insurance, so an insured buyer may do better on a copay.
−Generic high-volume support, large patient base means less personalized attention than smaller competitors.

Zealthy

Pros

+Dedicated insurance coordinators handle prior authorizations, potentially bringing brand-name GLP-1 costs to $25/mo
+Multi-month supply options (3, 6, or 12 months), unique convenience most monthly-shipping competitors can't match
+Both compounded and brand-name (Wegovy, Zepbound) available with clinician-guided selection
+LegitScript certified with 4.5-star Review.io rating

Cons

−The $135 membership stacks on medication cost, so cash-pay semaglutide totals ~$286/mo, above average. The math works when you use the insurance coordination; cash payers should compare flat-rate platforms first.
−Young company (founded 2023) with a relatively small review base and less track record than established platforms. Confirm the coordination promise against your own insurance plan before enrolling.
−Prescription products are non-refundable once ordered, for any reason. Double-check dose and supply length before checkout.

Our Verdict

Hims edges out Zealthy with a score of 7.9/10 vs 7.2/10. If budget is your priority, Hims is from $149/mo compared to Zealthy at $286/mo for the first month, rises after. Choose Hims if you want: men who want a well-known publicly-traded brand and fda-approved wegovy through the 2026 novo nordisk partnership, but should know going in that hims' customer-experience signal is weaker than smaller competitors. Choose Zealthy if you want: insured users who want dedicated coordinators handling prior authorizations for brand-name glp-1s (potentially $25/mo).

Cheapest in our index

Embody

$69/mo flat rate · 7.3/10 · Compounded

Both Hims and Zealthy start above the cheapest program we track. Across all 53 providers in our index, that floor is Embody at a flat $69/mo, the same rate at every dose, price checked July 31, 2026. It scores 7.3/10 and is not the highest-scored provider in our full rankings, so this is a cost floor rather than a recommendation. Worth knowing before you decide.